SCHEMBL7415546

SCHEMBL7415546

N#CC1(N(Cc2ccccc2)C(=O)C(C(N)=O)c2ccc(Cl)cc2)CCNC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 3/20 0.34
PSEN2 P49810 3/20 0.34
APH1B Q8WW43 3/20 0.34
NCSTN Q92542 3/20 0.34
APH1A Q96BI3 3/20 0.34
PSENEN Q9NZ42 3/20 0.34
CNR2 P34972 1/20 0.32
SLC6A9 P48067 2/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
SLC6A5 Q9Y345 1/20 0.32
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
AGER Q15109 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
UTS2R Q9UKP6 1/20 0.31
MDM2 Q00987 1/20 0.31
GHSR Q92847 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6371524 0.78 L3MBTL1 (0.40) CTSSCTSKKDM4EALDH1A1GHSR
SCHEMBL7419141 0.75 AGER (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7021618 0.75 SNCA (0.34) CYP2D6CTSSCTSK
SCHEMBL7419135 0.74 CTSS (0.45) CTSSCTSKAGER
SCHEMBL7021621 0.74 RXFP1 (0.34) CYP2D6CTSSCTSK
SCHEMBL7415538 0.74 ADRA1D (0.32) CYP2D6CTSSCTSKKDM4EALDH1A1
SCHEMBL7420196 0.73 CTSS (0.36) CYP2D6CTSSCTSK
SCHEMBL7420833 0.72 L3MBTL1 (0.41) CTSSCTSKKDM4EALDH1A1GHSR
SCHEMBL7420191 0.71 SNCA (0.34) CYP2D6CTSSCTSK
SCHEMBL7419241 0.70 CTSL (0.43) CTSSCTSKKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed